263 related articles for article (PubMed ID: 22520016)
1. Microparticle-associated tissue factor activity, venous thromboembolism and mortality in pancreatic, gastric, colorectal and brain cancer patients.
Thaler J; Ay C; Mackman N; Bertina RM; Kaider A; Marosi C; Key NS; Barcel DA; Scheithauer W; Kornek G; Zielinski C; Pabinger I
J Thromb Haemost; 2012 Jul; 10(7):1363-70. PubMed ID: 22520016
[TBL] [Abstract][Full Text] [Related]
2. Microparticle-associated tissue factor activity in patients with pancreatic cancer: correlation with clinicopathological features.
Thaler J; Ay C; Mackman N; Metz-Schimmerl S; Stift J; Kaider A; Müllauer L; Gnant M; Scheithauer W; Pabinger I
Eur J Clin Invest; 2013 Mar; 43(3):277-85. PubMed ID: 23398637
[TBL] [Abstract][Full Text] [Related]
3. Hemostatic Biomarkers and Venous Thromboembolism Are Associated With Mortality and Response to Chemotherapy in Patients With Pancreatic Cancer.
Moik F; Prager G; Thaler J; Posch F; Wiedemann S; Schramm T; Englisch C; Mackman N; Pabinger I; Ay C
Arterioscler Thromb Vasc Biol; 2021 Nov; 41(11):2837-2847. PubMed ID: 34470475
[TBL] [Abstract][Full Text] [Related]
4. Increased microparticle tissue factor activity in cancer patients with Venous Thromboembolism.
Manly DA; Wang J; Glover SL; Kasthuri R; Liebman HA; Key NS; Mackman N
Thromb Res; 2010 Jun; 125(6):511-2. PubMed ID: 19854471
[TBL] [Abstract][Full Text] [Related]
5. Circulating microparticles of glial origin and tissue factor bearing in high-grade glioma: a potential prothrombotic role.
Sartori MT; Della Puppa A; Ballin A; Campello E; Radu CM; Saggiorato G; d'Avella D; Scienza R; Cella G; Simioni P
Thromb Haemost; 2013 Aug; 110(2):378-85. PubMed ID: 23803674
[TBL] [Abstract][Full Text] [Related]
6. Circulating microparticle tissue factor, thromboembolism and survival in pancreaticobiliary cancers.
Bharthuar A; Khorana AA; Hutson A; Wang JG; Key NS; Mackman N; Iyer RV
Thromb Res; 2013 Aug; 132(2):180-4. PubMed ID: 23856554
[TBL] [Abstract][Full Text] [Related]
7. Tissue factor expressed by microparticles is associated with mortality but not with thrombosis in cancer patients.
Hernández C; Orbe J; Roncal C; Alvarez-Hernandez M; Martinez de Lizarrondo S; Alves MT; García Mata J; Páramo JA
Thromb Haemost; 2013 Sep; 110(3):598-608. PubMed ID: 23803792
[TBL] [Abstract][Full Text] [Related]
8. Extracellular vesicles exposing tissue factor for the prediction of venous thromboembolism in patients with cancer: A prospective cohort study.
van Es N; Hisada Y; Di Nisio M; Cesarman G; Kleinjan A; Mahé I; Otten HM; Kamphuisen PW; Berckmans RJ; Büller HR; Mackman N; Nieuwland R
Thromb Res; 2018 Jun; 166():54-59. PubMed ID: 29656167
[TBL] [Abstract][Full Text] [Related]
9. Tissue Factor As a Predictor of Recurrent Venous Thromboembolism in Malignancy: Biomarker Analyses of the CATCH Trial.
Khorana AA; Kamphuisen PW; Meyer G; Bauersachs R; Janas MS; Jarner MF; Lee AY
J Clin Oncol; 2017 Apr; 35(10):1078-1085. PubMed ID: 28029329
[TBL] [Abstract][Full Text] [Related]
10. Coagulation activation and microparticle-associated coagulant activity in cancer patients. An exploratory prospective study.
van Doormaal F; Kleinjan A; Berckmans RJ; Mackman N; Manly D; Kamphuisen PW; Richel DJ; Büller HR; Sturk A; Nieuwland R
Thromb Haemost; 2012 Jul; 108(1):160-5. PubMed ID: 22535219
[TBL] [Abstract][Full Text] [Related]
11. Microparticle-associated tissue factor activity: a link between cancer and thrombosis?
Tesselaar ME; Romijn FP; Van Der Linden IK; Prins FA; Bertina RM; Osanto S
J Thromb Haemost; 2007 Mar; 5(3):520-7. PubMed ID: 17166244
[TBL] [Abstract][Full Text] [Related]
12. Association between micro particle-tissue factor activity, factor VIII activity and recurrent VTE in patients with acute pulmonary embolism.
Kooiman J; den Exter PL; Kilicsoy I; Cannegieter SC; Eikenboom J; Huisman MV; Klok FA; Versteeg HH
J Thromb Thrombolysis; 2015 Oct; 40(3):323-30. PubMed ID: 25665657
[TBL] [Abstract][Full Text] [Related]
13. Intratumoral tissue factor expression and risk of venous thromboembolism in brain tumor patients.
Thaler J; Preusser M; Ay C; Kaider A; Marosi C; Zielinski C; Pabinger I; Hainfellner JA
Thromb Res; 2013 Feb; 131(2):162-5. PubMed ID: 23084660
[TBL] [Abstract][Full Text] [Related]
14. Microparticle-associated tissue factor activity in patients with metastatic pancreatic cancer and its effect on fibrin clot formation.
Thaler J; Koder S; Kornek G; Pabinger I; Ay C
Transl Res; 2014 Feb; 163(2):145-50. PubMed ID: 23973167
[TBL] [Abstract][Full Text] [Related]
15. Venous thromboembolism in patients with pancreatic cancer: implications of circulating tissue factor.
Delluc A; Rousseau A; Delluc C; Le Moigne E; Le Gal G; Mottier D; Van Dreden P; Lacut K
Blood Coagul Fibrinolysis; 2011 Jun; 22(4):295-300. PubMed ID: 21372691
[TBL] [Abstract][Full Text] [Related]
16. Endothelial, platelet, and tissue factor-bearing microparticles in cancer patients with and without venous thromboembolism.
Campello E; Spiezia L; Radu CM; Bulato C; Castelli M; Gavasso S; Simioni P
Thromb Res; 2011 May; 127(5):473-7. PubMed ID: 21256535
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of tissue factor in patients with pancreatic cancer: a systematic review protocol.
Li H; Yu Y; Shi Q; Chen X; Zheng P; Wang D; Tao P; Gu B; Li X; Zhang T; Xiang L; Xi D; Gao L; Maswikiti Ewetse P; Chen H
BMJ Open; 2020 Sep; 10(9):e037431. PubMed ID: 32928856
[TBL] [Abstract][Full Text] [Related]
18. Microvesicle-associated tissue factor procoagulant activity for the preoperative diagnosis of ovarian cancer.
Claussen C; Rausch AV; Lezius S; Amirkhosravi A; Davila M; Francis JL; Hisada YM; Mackman N; Bokemeyer C; Schmalfeldt B; Mahner S; Langer F
Thromb Res; 2016 May; 141():39-48. PubMed ID: 26967531
[TBL] [Abstract][Full Text] [Related]
19. Tissue factor-bearing microparticles and CA19.9: two players in pancreatic cancer-associated thrombosis?
Woei-A-Jin FJ; Tesselaar ME; Garcia Rodriguez P; Romijn FP; Bertina RM; Osanto S
Br J Cancer; 2016 Jul; 115(3):332-8. PubMed ID: 27404454
[TBL] [Abstract][Full Text] [Related]
20. Tissue factor-bearing microparticles and inflammation: a potential mechanism for the development of venous thromboembolism in cancer.
Date K; Ettelaie C; Maraveyas A
J Thromb Haemost; 2017 Dec; 15(12):2289-2299. PubMed ID: 29028284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
